Enrolling by invitationNCT05133245
PHACE - Prospective Genetic Investigation
Studying PHACE syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Karen Joos, MD, PhD, MDVanderbilt Eye Institute
- Intervention
- Diagnostic study only(other)
- Enrollment
- 50 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Vanderbilt Eye Institute, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05133245 on ClinicalTrials.gov